Menu

Oct 31, 2025
| Ginkgo Bioworks Extends Strategic Partnership with Bayer to Accelerate Agricultural Biologicals arrow_forward

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (32)

Company Market Cap Price
TMO Thermo Fisher Scientific Inc.
Thermo Fisher sells laboratory reagents used in molecular biology and analytical workflows.
$214.25B
$567.41
+2.01%
DHR Danaher Corporation
Danaher owns antibody and reagent businesses (e.g., Abcam, Genedata-related assets) providing laboratory reagents used in diagnostics and research.
$154.22B
$215.38
+0.15%
A Agilent Technologies, Inc.
Consumables and reagents for lab workflows (laboratory reagents) are part of Agilent's product portfolio.
$41.58B
$146.35
+2.09%
ILMN Illumina, Inc.
Laboratory reagents and consumables used in sequencing workflows are a key recurring revenue product for Illumina's platform.
$18.99B
$123.61
+24.85%
QGEN Qiagen N.V.
QIAGEN sells laboratory reagents and kits used in molecular biology and analytical workflows.
$10.49B
$46.85
+1.13%
DCI Donaldson Company, Inc.
Laboratory reagents used in bioprocessing workflows (e.g., IsoTag AAV reagent) within Life Sciences.
$9.82B
$84.19
+0.60%
TECH Bio-Techne Corporation
Bio-Techne supplies laboratory reagents used across proteomics, nucleic acid analysis, and related workflows.
$9.81B
$62.55
+2.61%
BIO Bio-Rad Laboratories, Inc.
Bio-Rad provides laboratory reagents and kits used for molecular biology and analytical workflows.
$8.65B
$320.03
+5.06%
AVTR Avantor, Inc.
Reagents and kits used in molecular biology and analytical workflows are central to Avantor's product mix.
$8.06B
$11.83
+7.06%
GRFS Grifols, S.A.
Grifols produces Laboratory Reagents used in diagnostic and analytical workflows.
$6.44B
$9.35
+2.07%
BRKR Bruker Corporation
Bruker-level reagents and kit offerings (from acquisitions like RECIPE and Biocrates) support laboratory workflows.
$5.90B
$38.95
+7.01%
QDEL QuidelOrtho Corporation
Laboratory reagents form a core component of the company’s recurring revenue in its Labs and Molecular Diagnostics offerings.
$1.83B
$27.00
+0.71%
TXG 10x Genomics, Inc.
TXG offers laboratory reagents/kits (GEM, Visium, Xenium chemistries) used in its workflows.
$1.68B
$13.62
+9.49%
NEOG Neogen Corporation
Culture media, reagents, and related laboratory consumables align with Laboratory Reagents.
$1.34B
$6.17
+2.75%
BLFS BioLife Solutions, Inc.
CryoStor and HypoThermosol are laboratory reagents/biopreservation media used in CGT workflows.
$1.33B
$27.91
+3.75%
DNA Ginkgo Bioworks Holdings, Inc.
Proprietary laboratory reagents, including cell-free protein synthesis kits, are sold as a product.
$760.33M
$12.99
+8.16%
PACB Pacific Biosciences of California, Inc.
PacBio provides laboratory reagents and consumables used in sequencing workflows (chemistries, SMRT Cells).
$702.20M
$2.35
+20.88%
KODK Eastman Kodak Company
FDA-registered cGMP facility producing phosphate buffered saline (PBS) represents Laboratory Reagents.
$507.20M
$6.34
-0.24%
CTKB Cytek Biosciences, Inc.
Laboratory reagents for use with Cytek's instruments (e.g., dye panels, antibodies) anticipated growth.
$493.97M
$3.89
+1.83%
LAB Standard BioTools Inc.
SomaScan reagents and kits used in proteomics workflows.
$455.79M
$1.20
+4.35%
QSI Quantum-Si incorporated
Sequencing and library preparation kits are consumables/reagents sold for NGPS workflows.
$394.52M
$2.14
+5.42%
SRDX Surmodics, Inc.
The IVD segment is a stable revenue stream; Surmodics supplies laboratory reagents/components used in immunoassays.
$392.30M
$27.49
+1.18%
TKNO Alpha Teknova, Inc.
Teknova’s core offerings are life-science reagents (Lab Essentials and Clinical Solutions), i.e., laboratory reagents supplied to RUO and GMP markets.
$280.56M
$5.25
+3.66%
QTRX Quanterix Corporation
Produces and supplies laboratory reagents and kits used in assays, including materials from Emission, Inc. acquisition.
$207.35M
$5.34
+6.90%
NAUT Nautilus Biotechnology, Inc.
Nautilus uses proprietary multi-affinity probes and related consumables as part of the proteoform detection workflow.
$167.99M
$1.33
-5.32%
SEER Seer, Inc.
Engineered nanoparticles and related reagents used as consumables map to Laboratory Reagents.
$130.10M
$2.20
-1.35%
AKYA Akoya Biosciences, Inc.
PhenoCode molecular barcode reagents and other assay panels sold for high-plex spatial biology workflows.
$64.26M
$1.29
JANL Janel Corporation
Reagents produced by the Life Sciences segment are a direct product category (laboratory reagents).
$37.96M
$32.00
DYAI Dyadic International, Inc.
Company produces RNase/DNase enzymes, RNase inhibitors, polymerases, and other laboratory reagents used in molecular biology and diagnostics.
$34.00M
$1.14
-2.56%
PRPO Precipio, Inc.
Laboratory reagents used in diagnostics (e.g., HemeScreen panels and IV-Cell media).
$31.00M
$20.83
+1.76%
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
IVF media production facility implies production of laboratory media/reagents for reproductive technology.
$17.61M
$0.97
+10.39%
CODX Co-Diagnostics, Inc.
In-house oligonucleotide reagents (e.g., Co-Primers) and related kits are manufactured for platform assays.
$15.51M
$0.46
-1.20%

Loading company comparison...

Loading research report...

DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Extends Strategic Partnership with Bayer to Accelerate Agricultural Biologicals

Oct 31, 2025
BIO Bio-Rad Laboratories, Inc.

Bio‑Rad Reports Q3 2025 Results: Revenue Up 0.5%, Net Loss Due to Fair‑Value Adjustment

Oct 30, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Announces Collaboration with STRM.BIO and UBC to Develop In‑Vivo CAR Therapies Under ARPA‑H EMBODY Program

Oct 23, 2025
PACB Pacific Biosciences of California, Inc.

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

Oct 14, 2025
PACB Pacific Biosciences of California, Inc.

PacBio Selected as Primary Platform for South Korea’s National Pangenome Project

Oct 13, 2025
PACB Pacific Biosciences of California, Inc.

PacBio Expands Partnership with seqWell to Offer Scalable Long‑Read Sample Preparation

Oct 07, 2025
QGEN Qiagen N.V.

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

Sep 10, 2025
QSI Quantum-Si incorporated

Quantum-Si Launches V4 Sequencing Kit, Expanding Proteome Coverage

Sep 08, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium for AI-Driven Biologics Discovery

Sep 04, 2025
QGEN Qiagen N.V.

U.S. FDA Clears Higher-Throughput QIAstat-Dx Rise System for Rapid Syndromic Testing

Sep 01, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Settles Shareholder Derivative Actions for $4.125 Million

Aug 29, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Datapoints Partners to Deploy AI-Driven Lab-in-the-Loop Workflows for Biopharma

Aug 20, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Drive External Growth

Aug 12, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Reports Q2 2025 Financial Results, Achieves $250 Million Cost Savings Target Early

Aug 07, 2025
QGEN Qiagen N.V.

QIAGEN Exceeds Q2 2025 Outlook, Raises Full-Year Sales Guidance

Aug 05, 2025
QSI Quantum-Si incorporated

Quantum-Si Reports Q2 2025 Financial Results Amid NIH Funding Challenges

Aug 05, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Secures $4.66 Million Contract with PNNL for Microbial Research Automation

Jul 30, 2025
QGEN Qiagen N.V.

QIAGEN Launches QIAseq xHYB Long Read Panels for NGS Portfolio Expansion

Jul 22, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Launches Cost-Competitive US-Based ADME Profiling Service

Jul 17, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Dropped from S&P TMI Index

Jul 09, 2025
AKYA Akoya Biosciences, Inc.

Quanterix Corporation Completes Acquisition of Akoya Biosciences

Jul 08, 2025
QSI Quantum-Si incorporated

Quantum-Si Announces Second $50 Million Registered Direct Offering

Jul 03, 2025
QGEN Qiagen N.V.

QIAGEN Adjusts Convertible Bond Conversion Prices Following Cash Dividend

Jul 02, 2025
QGEN Qiagen N.V.

QIAGEN N.V. Dropped from Russell 1000 Dynamic Index

Jun 30, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Dropped from Multiple Russell Indices

Jun 29, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. Added to Multiple Russell Indexes

Jun 29, 2025
QGEN Qiagen N.V.

Stephen Rusckowski Elected QIAGEN Supervisory Board Chairman; Dividend and Buyback Approved

Jun 26, 2025
QSI Quantum-Si incorporated

Quantum-Si Places Platinum Pro Instrument at Broad Institute

Jun 24, 2025
QGEN Qiagen N.V.

QIAGEN and GENCURIX Partner for QIAcuity Digital PCR IVD Oncology Assay Development

Jun 18, 2025
QGEN Qiagen N.V.

QIAGEN and Incyte Announce Precision Medicine Collaboration for MPN Companion Diagnostics

Jun 17, 2025
QSI Quantum-Si incorporated

Quantum-Si Single-Molecule Technology Enables Precise Nanobody Binding Measurement

Jun 10, 2025
QGEN Qiagen N.V.

QIAGEN Expands MRD Testing Portfolio with Strategic Partnerships for Oncology

Jun 02, 2025
AKYA Akoya Biosciences, Inc.

Kent Lake Urges Quanterix Not to Increase Offer Following Akoya's $1.40 Per Share Alternative Proposal

May 23, 2025
QGEN Qiagen N.V.

QIAGEN Partners with ID Solutions to Expand Digital PCR Oncology Research Portfolio

May 22, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Appoints Steven Coen as Chief Financial Officer

May 21, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Receives Unsolicited All-Cash Acquisition Proposal at $1.40 Per Share

May 20, 2025
QSI Quantum-Si incorporated

Quantum-Si Reports Q1 2025 Financial Results, Notes U.S. Market Headwinds

May 15, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Reports Q1 2025 Financial Results and Secures Debt Covenant Waiver

May 12, 2025
QGEN Qiagen N.V.

QIAGEN Acquires Genoox to Enhance Clinical Genomics Portfolio with AI Software

May 12, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Twist Bioscience Revise Collaboration Agreement

May 08, 2025
QGEN Qiagen N.V.

QIAGEN Reports Strong Q1 2025 Results, Proposes Annual Dividend and New $500M Share Repurchase

May 07, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Reports Q1 2025 Financial Results, Reaffirms Full Year Guidance

May 06, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Phytolon Achieve Milestone, Nearly Tripling Natural Food Color Production Efficiency

Apr 30, 2025
AKYA Akoya Biosciences, Inc.

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Apr 28, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Launches New ADC Breast Cancer Assay and Presents IO60 Real-World Data at AACR 2025

Apr 24, 2025
AKYA Akoya Biosciences, Inc.

Akoya Biosciences Partners with Singapore Translational Cancer Consortium on SUPER Study

Apr 23, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Partners with Aura Genetics to Scale Direct-to-Consumer Diagnostic Testing

Apr 22, 2025
AKYA Akoya Biosciences, Inc.

Tikvah Management Calls for Explanation on Quanterix's Convertible Notes to Akoya Biosciences

Apr 14, 2025
QGEN Qiagen N.V.

QIAGEN Advances Plans for Three New Automated Sample Preparation Instruments by 2026

Apr 14, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Partners Awarded $29 Million ARPA-H Contract for Pharmaceutical Supply Chain Stabilization

Apr 10, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks